Accessibility Help | Sitemap | Contact Us | Customer Support CALL 800-668-5403
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support

Welcome to KCI, Leader in Advanced Wound Care Solutions

Features

News   Medical Professionals   Patient Stories
KCI, Leader in Advanced Wound Care Solutions KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity
Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue
Prevena Incision Management System Prevena Incision Management System
The first and only powered negative pressure product designed specifically for management of incisions at risk of post-operative complications.
Nigels Story - VAC Nigel’s Story
See how V.A.C.® Therapy helped a soldier win the fight against a terrible wound.
KCI, Leader in Advanced Wound Care Solutions New Study Reported Prevena™ Therapy Patients had a Significantly Lower Infection Rate Following Cardiac Surgery Compared to Control Group
Surgical incision management could generate savings of more than 60 million Euros in Germany alone
V.A.C. Ulta Negative Therapy System V.A.C.Ulta™ Negative Pressure Wound Therapy System
V.A.C.Ulta™ Negative Pressure Wound Therapy System with V.A.C. VeraFlo™ Therapy is the first and only NPT System with instillation therapy featuring both soak time and automated volumetric delivery of topical wound treatment solutions to the wound bed.

V.A.C.® Therapy Reimbursement

Image of the ActiV.A.C. Therapy System

More information on reimbursement

About KCI

KCI is committed to advancing healing technology that positively impacts the lives of patients, their families, caregivers and providers alike.


Important Message for Patients

Legal Notice | Privacy Policy | Contact Us


© 1998 – 2013 KCI Licensing, Inc. All Rights Reserved. DSL# 09-03-193.CA

The information included in this Web site has been prepared for and is intended for viewing exclusively within Canada. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.